Rang	Name	Position
1	Mr. Raymond F. Vennare	CEO & Chairman
2	Mr. Joshua Blacher CPA, M.B.A.	Interim Chief Financial Officer
3	Mr. Thomas McLaughlin	Chief Investment Officer
4	Ms. Sara Turken J.D.	Senior VP & General Counsel
5	Dr. Lawrence J. DeLucas D.Sc, O.D, Ph.D.	Senior Vice President of Biologics
6	Dr. Arlette H. Uihlein FCAP, M.D.	Senior VP of Translational Medicine & Drug Discovery and Medical Director

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Vanguard Group Inc	0,62%	0,13 Mio. USD
2	Geode Capital Management, LLC	0,55%	0,11 Mio. USD
3	Virtu Financial LLC	0,14%	0,03 Mio. USD
4	State Street Corp	0,12%	0,02 Mio. USD
5	Carnegie Mellon University	0,09%	0,02 Mio. USD
6	Tower Research Capital LLC	0,01%	0,00 Mio. USD
7	Wells Fargo & Co	0,01%	0,00 Mio. USD
8	Advisor Group Holdings, Inc.	0,00%	0,00 Mio. USD
9	Bank of America Corp	0,00%	0,00 Mio. USD
10	Royal Bank of Canada	0,00%	0,00 Mio. USD
11	SBI Securities Co Ltd	0,00%	0,00 Mio. USD
12	Jane Street Group LLC	0,00%	0,00 Mio. USD
13	PSI Advisors, LLC	0,00%	0,00 Mio. USD
14	Federation des caisses Desjardins du Quebec	0,00%	0,00 Mio. USD
15	Citigroup Inc	0,00%	0,00 Mio. USD
16	UBS Group AG	0,00%	0,00 Mio. USD
17	Csenge Advisory Group, LLC	0,00%	0,00 Mio. USD
18	Two Sigma Investments LLC	0,00%	0,00 Mio. USD
19	XTX Topco Ltd	0,00%	0,00 Mio. USD